Neural Cell News Volume 16.15 | Apr 20 2022

    0
    28







    2022-04-20 | NCN 16.15


    Neural Cell News by STEMCELL Technologies
    Vol. 16.15 – 20 April, 2022
    TOP STORY

    Somatic Genomic Changes in Single Alzheimer’s Disease Neurons

    Researchers analyzed single-cell whole-genome sequencing data from 319 neurons from the prefrontal cortex and hippocampus of individuals with Alzheimer’s disease and neurotypical control individuals.
    [Nature]

    AbstractPress Release
    Tips to prepare for your next conference or networking event
    PUBLICATIONSRanked by the impact factor of the journal

    Concerted Type I Interferon Signaling in Microglia and Neural Cells Promotes Memory Impairment Associated with Amyloid β Plaques

    Investigators revealed brain-wide cellular reactions to type I interferon, an innate immune cytokine aberrantly elicited by amyloid β plaques, and examined their role in cognition and neuropathology relevant to Alzheimer’s disease in a murine amyloidosis model.
    [Immunity]

    AbstractGraphical Abstract

    Dormant State of Quiescent Neural Stem Cells Links Shank3 Mutation to Autism Development

    Scientists reported that the dormancy of quiescent neural stem cells was a therapeutic target for controlling the development of autism spectrum disorder phenotypes driven by Shank3 deficiency.
    [Molecular Psychiatry]

    Abstract

    The Role of PTEN in Primary Sensory Neurons in Processing Itch and Thermal Information in Mice

    The authors reported that PTEN in primary sensory neurons was involved in processing itch and thermal information in adult mice.
    [Cell Reports]

    Full ArticleGraphical Abstract

    Role of Upregulation of the KATP Channel Subunit SUR1 in Dopaminergic Neuron Degeneration in Parkinson’s Disease

    Investigators revealed the regulatory mechanism of the SUR1 subunit and the role of ATP-sensitive potassium (KATP) channels in the progression of dopaminergic neuron degeneration.
    [Aging Cell]

    Full Article

    Cdk5 Phosphorylation-Induced SIRT2 Nuclear Translocation Promotes the Death of Dopaminergic Neurons in Parkinson’s Disease

    The authors showed that NAD-dependent protein deacetylase sirtuin 2 (SIRT2) knockout was able to effectively ameliorate anomalous behavioral phenotypes in transgenic mouse models of Parkinson’s disease.
    [npj Parkinson’s Disease]

    Full Article

    NOX Activation in Reactive Astrocytes Regulates Astrocytic LCN2 Expression and Neurodegeneration

    Scientists investigated the role of astrocytic Na+/H+ exchanger 1 in regulating reactive astrocyte lipocalin-2 (LCN2) secretion and neurodegeneration after stroke.
    [Cell Death & Disease]

    Full Article

    Failure of DNA Double-Strand Break Repair by Tau Mediates Alzheimer’s Disease Pathology In Vitro

    In vitro studies using primary mouse cortical neurons showed that non-p-tau accumulated perinuclearly together with the tubulin after double-strand break induction with etoposide.
    [Communications Biology]

    Full Article

    GBP2 Facilitates the Progression of Glioma via Regulation of KIF22/EGFR Signaling

    In glioma cells, depletion of guanylate-binding protein 2 (GBP2) impaired proliferation and migration, whereas overexpression of GBP2 enhanced proliferation and migration.
    [Cell Death Discovery]

    Full Article

    Identification of Ubiquitin-Specific Protease 32 as an Oncogene in Glioblastoma and the Underlying Mechanisms

    Researchers evaluated the role of ubiquitin-specific protease 32 (USP32) in glioblastoma (GBM) progression and provided a potential target for GBM treatment. The clinical significance of USP32 was investigated using Gene Expression Omnibus databases.
    [Scientific Reports]

    Full Article
    Survey results on the needs and challenges in the human pluripotent stem cell field
    REVIEWS

    Programming Axonal Mitochondrial Maintenance and Bioenergetics in Neurodegeneration and Regeneration

    Investigators discuss recent advances in how neurons maintain a healthy pool of axonal mitochondria, as well as potential therapeutic strategies that target bioenergetic restoration to power neuronal survival, function, and regeneration.
    [Neuron]

    Abstract

    The Synapse as a Treatment Avenue for Alzheimer’s Disease

    The authors address the underlying mechanisms behind synaptic loss and dysfunction in Alzheimer’s disease and discuss potential strategies that target the synapse.
    [Molecular Psychiatry]

    Abstract
    INDUSTRY AND POLICY NEWS

    Neuraly Announces Completion of Enrollment in Phase II Clinical Trial of NLY01 in Patients with Parkinson’s Disease

    Neuraly announced the completion of patient enrollment in its Phase II study of NLY01 for Parkinson’s disease.
    [Neuraly, Inc. (Business Wire)]

    Press Release

    Neuropore Therapies Awarded $4.8M Grant from The Michael J. Fox Foundation for Parkinson’s Research to Support Development of Its TLR2 Program

    Neuropore Therapies, Inc. announced that it received a $4.8M grant from The Michael J. Fox Foundation for Parkinson’s Research. The grant will be used to support the preclinical and clinical development of a novel brain-penetrating small molecule Toll-Like receptor 2 (TLR2) antagonist.
    [Neuropore Therapies, Inc.]

    Press Release
    FEATURED EVENT

    Myelin

    May 22 – 27, 2022
    Lucca, Italy

    > See All Events

    JOB OPPORTUNITIES

    PhD Student – Neuronal Circuits

    Max Delbrück Center for Molecular Medicine – Berlin, Germany

    Postdoctoral – Neuroscience/Immunology

    University of California, San Diego – La Jolla, California, United States

    Postdoctoral Fellow – Neurology and Neurobiology

    University of California Los Angeles – Los Angeles, California, United States

    Postdoctoral Position – Neurology

    University of Pittsburgh School of Medicine – Pittsburgh, Pennsylvania, United States

    Postdoctoral Fellow – Retinal Neurodegeneration

    University of British Columbia – Vancouver, British Columbia, Canada

    > See All Jobs

    Submit an article, publication, job or event
    Brought to you by
    stemcell-logo-for newsletter-2
    Neural Cell News Twitter